Cintredekin besudotox (USAN/INN)

C2234H3512N650O682S10

50677.7321

50708.41

MHSPGPVPPS TALRELIEEL VNITQNQKAP LCNGSMVWSI NLTAGMYCAA LESLINVSGC
SAIEKTQRML SGFCPHKVSA GQFSSLHVRD TKIEVAQFVK DLLLHLKKLF REGRFNKASG
GPEGGSLAAL TAHQACHLPL ETFTRHRQPR GWEQLEQCGY PVQRLVALYL AARLSWNQVD
QVIRNALASP GSGGDLGEAI REQPEQARLA LTLAAAESER FVRQGTGNDE AGAANGPADS
GDALLERNYP TGAEFLGDGG DVSFSTRGTQ NWTVERLLQA HRQLEERGYV FVGYHGTFLE
AAQSIVFGGV RARSQDLDAI WRGFYIAGDP ALAYGYAQDQ EPDARGRIRN GALLRVYVPR
SSLPGFYRTS LTLAAPEAAG EVERLIGHPL PLRLDAITGP EEEGGRLETI LGWPLAERTV
VIPSAIPTDP RNVGGDLDPS SIPDQEQAIS ALPDYASQPG QPPREDLR
(Disulfide bridge: 32-60, 48-74, 136-158)

Antineoplastic

interleukin 13 (IL13) [HSA:3596] [KO:K05435] analog
Treatment of malignant glioma, including glioblastoma multiforme and anaplastic astrocytoma